The Management of Hypertensive Emergencies-Is There a "Magical" Prescription for All?
Ana-Maria BalahuraȘtefan-Ionuț MoroiAlexandru Scafa-UdrişteEmma WeissCristina JapieDaniela BartoşElisabeta BădilăPublished in: Journal of clinical medicine (2022)
Hypertensive emergencies (HE) represent high cardiovascular risk situations defined by a severe increase in blood pressure (BP) associated with acute, hypertension mediated organ damage (A-HMOD) to the heart, brain, retina, kidneys, and large arteries. Blood pressure values alone do not accurately predict the presence of HE; therefore, the search for A-HMOD should be the first step in the management of acute severe hypertension. A rapid therapeutic intervention is mandatory in order to limit and promote regression of end-organ damage, minimize the risk of complications, and improve patient outcomes. Drug therapy for HE, target BP, and the speed of BP decrease are all dictated by the type of A-HMOD, specific drug pharmacokinetics, adverse drug effects, and comorbidities. Therefore, a tailored approach is warranted. However, there is currently a lack of solid evidence for the appropriate treatment strategies for most HE. This article reviews current pharmacological strategies while providing a stepwise, evidence based approach for the management of HE.
Keyphrases
- blood pressure
- adverse drug
- drug induced
- hypertensive patients
- liver failure
- heart rate
- respiratory failure
- randomized controlled trial
- oxidative stress
- early onset
- electronic health record
- aortic dissection
- emergency department
- atrial fibrillation
- systematic review
- resting state
- functional connectivity
- intensive care unit
- smoking cessation
- multiple sclerosis
- hepatitis b virus
- blood brain barrier
- quantum dots
- mechanical ventilation